Sputnik v, a coronavirus (Covid-19) vaccine produced by Russia's Gamaleya National Center, will be available in markets around the world starting early next week. Dr Reddy's Laboratories, located in hyderabad, will produce the vaccine in India. The drugs Controller General of india (DCGI) granted Sputnik v emergency use authorization (EUA) in April. It will be the third vaccine shot given in India; the other two vaccine shots are Covishield and Covaxin. The Russian Direct Investment Fund (RDIF) has signed an agreement with india to develop 750 million Sputniks.

On august 11 of last year, russia became the first country to authorise the Sputnik v Covid-19 vaccine. According to the Lancet Medical Journal, the vaccine has a 91.6 per cent effectiveness rate and has been cleared and licenced for widespread use in more than 50 countries. Beginning May 1, any person over the age of 18 became eligible for a vaccine as part of the third step of the national vaccination campaign.

Covishield and Covaxin are the other two shots. The Oxford University-AstraZeneca shot is manufactured by Serum Institute of india (SII) in pune, while Covaxin was developed by Bharat Biotech international Limited in Hyderabad.

మరింత సమాచారం తెలుసుకోండి:

Vaccine Hyderabad Russia Sputnik hyderabad university august international april pune reddy

Sachin

13/05/2021 05:39 PM